Pasha Hajar, Basirat Zahra, Faramarzi Mahbobeh, Kheirkhah Farzan
Infertility and Reproductive Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Infertility and Reproductive Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Int J Fertil Steril. 2018 Apr;12(1):6-12. doi: 10.22074/ijfs.2018.5229. Epub 2018 Jan 7.
Fertility loss is considered as a challenging experience. This study was conducted to compare the effectiveness of antidepressant medication and psychological intervention on depression symptoms in women with infertility and sexual dysfunctions (SD).
This randomized, controlled clinical trial study was completed from December 2014 to June 2015 in Babol, Iran. Of the 485 participants, 93 were randomly assigned in a 1:1:1 ratio to psychosexual therapy (PST), bupropion extended-release (BUP ER) at a dose of 150 mg/d, and control (no intervention) groups. The beck depression inventory (BDI) was completed at the beginning and end of the study. Duration of study was eight weeks. Statistical analyses were performed by using paired-test and analysis of covariance.
The mean depression score on the BDI was 22.35 ± 8.70 in all participants. Mean BDI score decreased significantly in both treatment groups (PST: P<0.0001, BUP: P<0.002) from baseline to end of the study, whereas intra-individual changes in BDI score were not significant in the control group. The decrease in mean BDI score was greater with PST compared to BUP treatment (P<0.005) and the control group (P<0.0001). The PST group showed greater improvement in depression levels (severe to moderate, moderate to mild) in comparison with the two other groups (P<0.001). Drug treatment was well tolerated by the participants in the BUP group.
PST can be a reliable alternative to BUP ER for relieving depression symptoms in an Iranian population of women with infertility and SD (Registration number: IRCT2015042721955N2).
生育能力丧失被视为一种具有挑战性的经历。本研究旨在比较抗抑郁药物和心理干预对患有不孕症和性功能障碍(SD)的女性抑郁症状的疗效。
这项随机对照临床试验于2014年12月至2015年6月在伊朗巴博勒完成。在485名参与者中,93人以1:1:1的比例被随机分配到性心理治疗(PST)组、每日剂量为150毫克的安非他酮缓释片(BUP ER)组和对照组(不进行干预)。在研究开始和结束时完成贝克抑郁量表(BDI)。研究持续时间为八周。采用配对检验和协方差分析进行统计分析。
所有参与者的BDI平均抑郁评分为22.35±8.70。从基线到研究结束,两个治疗组(PST组:P<0.0001,BUP组:P<0.002)的BDI平均评分均显著降低,而对照组的BDI评分个体内变化不显著。与BUP治疗组(P<0.005)和对照组(P<0.0001)相比,PST组的BDI平均评分下降幅度更大。与其他两组相比,PST组在抑郁水平(从重度到中度、从中度到轻度)上有更大改善(P<0.001)。BUP组的参与者对药物治疗耐受性良好。
对于缓解伊朗患有不孕症和SD的女性群体的抑郁症状,PST可以作为BUP ER的可靠替代方法(注册号:IRCT2015042721955N2)。